Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for acute myocardial infarction undergoing primary PCI
IRCT20230620058546N1Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Jun 2023
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in myocardial infarction (MI) comparing Colchicine with Placebo (2 arms). Primary endpoints: TIMI flow before and after stent implantation, Troponin at baseline, 24 hours, and 48 hours and 4 more. Started Jun 2023; status: completed.
02
Drugs
colchicine
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on IRCT20230620058546N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230620058546N1.